De bør derfor følges tæt af læger med erfaring i behandling af sygdomme, som ledsager HIV.
Patients receiving Epivir or any other antiretroviral therapy may continue to develop opportunistic infections and other complications of HIV infection, and therefore should remain under close clinical observation by physicians experienced in the treatment of patients with associated HIV diseases.